sales@fnfresearch.comTel: +86 21 80360450 | USA: +1-347-989-3985

Search Market Research Report

Home / Healthcare / Plasmid

Healthcare /

Plasmid Market – by General Type (Conjugative and Non-Conjugative), by Specific Plasmid Types (F-Plasmids, Col Plasmids, Resistance Plasmids, Cryptic Plasmids, Degradative Plasmids, and Virulence Plasmids), and by Application (Transfection, Recombinant DNA Technology, Gene Therapy, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2019 – 2027

  • Publish On: Sep-2019
  • Total Pages: 110
  • Report Code: FAF-48
  • Base Year: 2018
  • Format:

Industry Insights

The report covers the forecast and analysis of the plasmid market on a global and regional level. The study provides historical data from 2015 to 2018 along with a forecast from 2019 to 2027 based on revenue (USD Million). The study includes drivers and restraints of the plasmid market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the plasmid market on a global level.

In order to give the users of this report a comprehensive view of the Telepathology service market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.

The report provides company market share analysis to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product &service launches, agreements, partnerships, collaborations &joint ventures, research & development, and regional expansion of major participants involved in the market on a global and regional basis.

The study provides a decisive view of the plasmid market by segmenting the market based on the general type, specific plasmid types, applications, and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2019 to 2027. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

Escalating awareness about the gene treatment along with the acceptance of gene therapy for treating chronic diseases like Alzheimer's and attention deficit hyperactivity will magnify the market surge over the forecast timeline. Moreover, gene therapy has a high potential for treating genetic disorders, as well as chronic ailments like cancer, and this will further enhance business expansion over the forecast timespan. Nonetheless, mutagenesis coupled with high costs related to gene treatment can act as an inhibiting factor for the plasmid industry over the period from 2019 to 2027.

Based on the general type, the market is divided into Conjugative and Non-Conjugative. On the basis of specific plasmid types, the industry is classified into F-Plasmids, Col Plasmids, Resistance Plasmids, Cryptic Plasmids, Degradative Plasmids, and Virulence Plasmids. Application-wise, the market is sectored into Transfection, Recombinant DNA Technology, Gene Therapy, and Others.

Key players involved in the plasmid industry include Aldevron, GenScript, PlasmidFactory GmbH & Co. KG, VGXI, Inc., Oxford Genetics Ltd., Applied StemCell, Altogen Biosystems, Cobra Biologics, Copernicus Therapeutics, Inc., Takara Bio Inc., InvivoGen, Miltenyi Biotec, Medigene Sdn Bhd, MaxCyte, Inc., Mirus Bio LLC, MolMed S.p.A., GenePharma, and Polyplus Transfection.

Table of Content

  • Chapter 1. Executive Summary 23
  • Chapter 2. Plasmid  market – General Type Plasmid Analysis 25
    • 2.1. Global Plasmid  Market – General Type Plasmid Overview 25
    • 2.2. Global Plasmid  Market Share, by General Type Plasmid, 2018 & 2025 (USD Million) 25
    • 2.3. Conjugative 27
      • 2.3.1. Global Conjugative Plasmid  Market, 2015-2027 (USD Million) 27
    • 2.4. Non-Conjugative 28
      • 2.4.1. Global Non-Conjugative  Plasmid  Market, 2015-2027 (USD Million) 28
  • Chapter 3. Plasmid  market – Specific Plasmid Types Analysis 28
    • 3.1. Global Plasmid  Market – Specific Plasmid Types Overview 28
    • 3.2. Global Plasmid  Market Share, by Specific Plasmid Types, 2018 & 2025 (USD Million) 29
    • 3.3. F-Plasmids 30
      • 3.3.1. Global F-Plasmids Plasmid  Market, 2015-2027 (USD Million) 30
    • 3.4. Resistance Plasmids 31
      • 3.4.1. Global Resistance Plasmids Plasmid  Market, 2015-2027 (USD Million) 31
    • 3.5. Virulence Plasmids 32
      • 3.5.1. Global Virulence Plasmids Plasmid  Market, 2015-2027 (USD Million) 32
    • 3.6. Degradative Plasmids 33
      • 3.6.1. Global Degradative Plasmids Plasmid  Market, 2015-2027 (USD Million) 33
    • 3.7. Col Plasmids 34
      • 3.7.1. Global Col Plasmids Plasmid  Market, 2015-2027 (USD Million) 34
    • 3.8. Cryptic Plasmids 35
      • 3.8.1. Global Cryptic Plasmids Plasmid  Market, 2015-2027 (USD Million) 35
  • Chapter 4. Plasmid  market – Application Analysis 35
    • 4.1. Global Plasmid  Market – Application Overview 35
    • 4.2. Global Plasmid  Market Share, by Application, 2018 & 2025 (USD Million) 36
    • 4.3. Transfection 37
      • 4.3.1. Global Transfection Plasmid  Market, 2015-2027 (USD Million) 37
    • 4.4. Gene Therapy 38
      • 4.4.1. Global Gene Therapy Plasmid  Market, 2015-2027 (USD Million) 38
    • 4.5. Recombinant DNA Technology 39
      • 4.5.1. Global Recombinant DNA Technology Plasmid  Market, 2015-2027 (USD Million) 39
    • 4.6. Others 40
      • 4.6.1. Global Others Plasmid  Market, 2015-2027 (USD Million) 40
  • Chapter 5. Plasmid  market – Regional Analysis 41
    • 5.1. Global Plasmid  Market Regional Overview 41
    • 5.2. Global Plasmid  Market Share, by Region, 2018 & 2025 (Value) 41
    • 5.3. North America 43
      • 5.3.1. North America Plasmid  Market size and forecast, 2015-2027 43
      • 5.3.2. North America Plasmid  Market, by Country, 2018 & 2025 (USD Million) 43
      • 5.3.3. North America Plasmid  Market, by General Type Plasmid, 2015-2027 45
        • 5.3.3.1. North America Plasmid  Market, by General Type Plasmid, 2015-2027 (USD Million) 45
      • 5.3.4. North America Plasmid  Market, by Specific Plasmid Types, 2015-2027 46
        • 5.3.4.1. North America Plasmid  Market, by Specific Plasmid Types, 2015-2027 (USD Million) 46
      • 5.3.5. North America Plasmid  Market, by Application, 2015-2027 47
        • 5.3.5.1. North America Plasmid  Market, by Application, 2015-2027 (USD Million) 47
      • 5.3.6. U.S. 48
        • 5.3.6.1. U.S. Market size and forecast, 2015-2027 (USD Million) 48
      • 5.3.7. Canada 49
        • 5.3.7.1. Canada Market size and forecast, 2015-2027 (USD Million) 49
      • 5.3.8. Mexico 50
        • 5.3.8.1. Mexico Market size and forecast, 2015-2027 (USD Million) 50
    • 5.4. Europe 51
      • 5.4.1. Europe Plasmid  Market size and forecast, 2015-2027 51
      • 5.4.2. Europe Plasmid  Market, by Country, 2018 & 2025 (USD Million) 51
      • 5.4.3. Europe Plasmid  Market, by General Type Plasmid, 2015-2027 53
        • 5.4.3.1. Europe Plasmid  Market, by General Type Plasmid, 2015-2027 (USD Million) 53
      • 5.4.4. Europe Plasmid  Market, by Specific Plasmid Types, 2015-2027 54
        • 5.4.4.1. Europe Plasmid  Market, by Specific Plasmid Types, 2015-2027 (USD Million) 54
      • 5.4.5. Europe Plasmid  Market, by Application, 2015-2027 55
        • 5.4.5.1. Europe Plasmid  Market, by Application, 2015-2027 (USD Million) 55
      • 5.4.6. Germany 56
        • 5.4.6.1. Germany Market size and forecast, 2015-2027 (USD Million) 56
      • 5.4.7. France 57
        • 5.4.7.1. France Market size and forecast, 2015-2027 (USD Million) 57
      • 5.4.8. U.K. 58
        • 5.4.8.1. U.K. Market size and forecast, 2015-2027 (USD Million) 58
      • 5.4.9. Italy 59
        • 5.4.9.1. Italy Market size and forecast, 2015-2027 (USD Million) 59
      • 5.4.10. Spain 60
        • 5.4.10.1. Spain Market size and forecast, 2015-2027 (USD Million) 60
      • 5.4.11. Nordic Countries 61
        • 5.4.11.1. Nordic Countries Market size and forecast, 2015-2027 (USD Million) 61
      • 5.4.12. Benelux Union 62
        • 5.4.12.1. Benelux Union Market size and forecast, 2015-2027 (USD Million) 62
      • 5.4.13. Rest of Europe 63
        • 5.4.13.1. Rest of Europe Market size and forecast, 2015-2027 (USD Million) 63
    • 5.5. Asia Pacific 64
      • 5.5.1. Asia Pacific Plasmid  Market size and forecast, 2015-2027 64
      • 5.5.2. Asia Pacific Plasmid  Market, by Country, 2018 & 2025 (USD Million) 64
      • 5.5.3. Asia Pacific Plasmid  Market, by General Type Plasmid, 2015-2027 66
        • 5.5.3.1. Asia Pacific Plasmid  Market, by General Type Plasmid, 2015-2027 (USD Million) 66
      • 5.5.4. Asia Pacific Plasmid  Market, by Specific Plasmid Types, 2015-2027 67
        • 5.5.4.1. Asia Pacific Plasmid  Market, by Specific Plasmid Types, 2015-2027 (USD Million) 67
      • 5.5.5. Asia Pacific Plasmid  Market, by Application, 2015-2027 68
        • 5.5.5.1. Asia Pacific Plasmid  Market, by Application, 2015-2027 (USD Million) 68
      • 5.5.6. China 69
        • 5.5.6.1. China Market size and forecast, 2015-2027 (USD Million) 69
      • 5.5.7. Japan 70
        • 5.5.7.1. Japan Market size and forecast, 2015-2027 (USD Million) 70
      • 5.5.8. India 71
        • 5.5.8.1. India Market size and forecast, 2015-2027 (USD Million) 71
      • 5.5.9. New Zealand 72
        • 5.5.9.1. New Zealand Market size and forecast, 2015-2027 (USD Million) 72
      • 5.5.10. Australia 73
        • 5.5.10.1. Australia Market size and forecast, 2015-2027 (USD Million) 73
      • 5.5.11. South  Korea 74
        • 5.5.11.1. South  Korea Market size and forecast, 2015-2027 (USD Million) 74
      • 5.5.12. South-East Asia 75
        • 5.5.12.1. South-East Asia Market size and forecast, 2015-2027 (USD Million) 75
      • 5.5.13. Rest of Asia Pacific 76
        • 5.5.13.1. Rest of Asia Pacific Market size and forecast, 2015-2027 (USD Million) 76
    • 5.6. Latin America 77
      • 5.6.1. Latin America Plasmid  Market size and forecast, 2015-2027 77
      • 5.6.2. Latin America Plasmid  Market, by Country, 2018 & 2025 (USD Million) 77
      • 5.6.3. Latin America Plasmid  Market, by General Type Plasmid, 2015-2027 79
        • 5.6.3.1. Latin America Plasmid  Market, by General Type Plasmid, 2015-2027 (USD Million) 79
      • 5.6.4. Latin America Plasmid  Market, by Specific Plasmid Types, 2015-2027 80
        • 5.6.4.1. Latin America Plasmid  Market, by Specific Plasmid Types, 2015-2027 (USD Million) 80
      • 5.6.5. Latin America Plasmid  Market, by Application, 2015-2027 81
        • 5.6.5.1. Latin America Plasmid  Market, by Application, 2015-2027 (USD Million) 81
      • 5.6.6. Brazil 82
        • 5.6.6.1. Brazil Market size and forecast, 2015-2027 (USD Million) 82
      • 5.6.7. Argentina 83
        • 5.6.7.1. Argentina Market size and forecast, 2015-2027 (USD Million) 83
      • 5.6.8. Rest of Latin America 84
        • 5.6.8.1. Rest of Latin America Market size and forecast, 2015-2027 (USD Million) 84
    • 5.7. The Middle-East and Africa 85
      • 5.7.1. The Middle-East and Africa Plasmid  Market size and forecast, 2015-2027 85
      • 5.7.2. The Middle-East and Africa Plasmid  Market, by Country, 2018 & 2025 (USD Million) 85
      • 5.7.3. The Middle-East and Africa Plasmid  Market, by General Type Plasmid, 2015-2027 87
        • 5.7.3.1. The Middle-East and Africa Plasmid  Market, by General Type Plasmid, 2015-2027 (USD Million) 87
      • 5.7.4. The Middle-East and Africa Plasmid  Market, by Specific Plasmid Types, 2015-2027 88
        • 5.7.4.1. The Middle-East and Africa Plasmid  Market, by Specific Plasmid Types, 2015-2027 (USD Million) 88
      • 5.7.5. The Middle-East and Africa Plasmid  Market, by Application, 2015-2027 89
        • 5.7.5.1. The Middle-East and Africa Plasmid  Market, by Application, 2015-2027 (USD Million) 89
      • 5.7.6. Saudi Arabia 90
        • 5.7.6.1. Saudi Arabia Market size and forecast, 2015-2027 (USD Million) 90
      • 5.7.7. UAE 91
        • 5.7.7.1. UAE Market size and forecast, 2015-2027 (USD Million) 91
      • 5.7.8. Egypt 92
        • 5.7.8.1. Egypt Market size and forecast, 2015-2027 (USD Million) 92
      • 5.7.9. Kuwait 93
        • 5.7.9.1. Kuwait Market size and forecast, 2015-2027 (USD Million) 93
      • 5.7.10. South Africa 94
        • 5.7.10.1. South Africa Market size and forecast, 2015-2027 (USD Million) 94
      • 5.7.11. Rest of Middle-East Africa 95
        • 5.7.11.1. Rest of Middle-East Africa Market size and forecast, 2015-2027 (USD Million) 95
  • Chapter 6. Plasmid  market – Competitive Landscape 96
    • 6.1. Competitor Market Share – Revenue 96
    • 6.2. Market Concentration Rate Analysis, Top 3 and Top 5 Players 98
    • 6.3. Strategic Development 99
      • 6.3.1. Acquisitions and Mergers 99
      • 6.3.2. New Products 99
      • 6.3.3. Research & Development Activities 99
  • Chapter 7. Company Profiles 100
    • 7.1. Aldevron 100
      • 7.1.1. Company Overview 100
      • 7.1.2. Aldevron Revenue and Gross Margin 100
      • 7.1.3. Product portfolio 101
      • 7.1.4. Recent initiatives 102
    • 7.2. GenScript 102
      • 7.2.1. Company Overview 102
      • 7.2.2. GenScript Revenue and Gross Margin 102
      • 7.2.3. Product portfolio 103
      • 7.2.4. Recent initiatives 104
    • 7.3. PlasmidFactory GmbH & Co. KG 104
      • 7.3.1. Company Overview 104
      • 7.3.2. PlasmidFactory GmbH & Co. KG Revenue and Gross Margin 104
      • 7.3.3. Product portfolio 105
      • 7.3.4. Recent initiatives 106
    • 7.4. VGXI, Inc. 106
      • 7.4.1. Company Overview 106
      • 7.4.2. VGXI, Inc. Revenue and Gross Margin 106
      • 7.4.3. Product portfolio 107
      • 7.4.4. Recent initiatives 108
    • 7.5. Oxford Genetics Ltd. 108
      • 7.5.1. Company Overview 108
      • 7.5.2. Oxford Genetics Ltd. Revenue and Gross Margin 108
      • 7.5.3. Product portfolio 109
      • 7.5.4. Recent initiatives 110
    • 7.6. Applied StemCell 110
      • 7.6.1. Company Overview 110
      • 7.6.2. Applied StemCell Revenue and Gross Margin 110
      • 7.6.3. Product portfolio 111
      • 7.6.4. Recent initiatives 112
    • 7.7. Altogen Biosystems 112
      • 7.7.1. Company Overview 112
      • 7.7.2. Altogen Biosystems Revenue and Gross Margin 112
      • 7.7.3. Product portfolio 113
      • 7.7.4. Recent initiatives 114
    • 7.8. Cobra Biologics 114
      • 7.8.1. Company Overview 114
      • 7.8.2. Cobra Biologics Revenue and Gross Margin 114
      • 7.8.3. Product portfolio 115
      • 7.8.4. Recent initiatives 116
    • 7.9. Copernicus Therapeutics, Inc. 116
      • 7.9.1. Company Overview 116
      • 7.9.2. Copernicus Therapeutics, Inc. Revenue and Gross Margin 116
      • 7.9.3. Product portfolio 117
      • 7.9.4. Recent initiatives 118
    • 7.10. Takara Bio Inc. 118
      • 7.10.1. Company Overview 118
      • 7.10.2. Takara Bio Inc. Revenue and Gross Margin 118
      • 7.10.3. Product portfolio 119
      • 7.10.4. Recent initiatives 120
    • 7.11. InvivoGen 120
      • 7.11.1. Company Overview 120
      • 7.11.2. InvivoGen Revenue and Gross Margin 120
      • 7.11.3. Product portfolio 121
      • 7.11.4. Recent initiatives 122
    • 7.12. Miltenyi Biotec 122
      • 7.12.1. Company Overview 122
      • 7.12.2. Miltenyi Biotec Revenue and Gross Margin 122
      • 7.12.3. Product portfolio 123
      • 7.12.4. Recent initiatives 124
    • 7.13. Medigene Sdn Bhd 124
      • 7.13.1. Company Overview 124
      • 7.13.2. Medigene Sdn Bhd Revenue and Gross Margin 124
      • 7.13.3. Product portfolio 125
      • 7.13.4. Recent initiatives 126
    • 7.14. MaxCyte, Inc. 126
      • 7.14.1. Company Overview 126
      • 7.14.2. MaxCyte, Inc. Revenue and Gross Margin 126
      • 7.14.3. Product portfolio 127
      • 7.14.4. Recent initiatives 128
    • 7.15. Mirus Bio LLC 128
      • 7.15.1. Company Overview 128
      • 7.15.2. Mirus Bio LLC Revenue and Gross Margin 128
      • 7.15.3. Product portfolio 129
      • 7.15.4. Recent initiatives 130
    • 7.16. MolMed S.p.A. 130
      • 7.16.1. Company Overview 130
      • 7.16.2. MolMed S.p.A. Revenue and Gross Margin 130
      • 7.16.3. Product portfolio 131
      • 7.16.4. Recent initiatives 132
    • 7.17. GenePharma 132
      • 7.17.1. Company Overview 132
      • 7.17.2. GenePharma Revenue and Gross Margin 132
      • 7.17.3. Product portfolio 133
      • 7.17.4. Recent initiatives 134
    • 7.18. Polyplus Transfection 134
      • 7.18.1. Company Overview 134
      • 7.18.2. Polyplus Transfection Revenue and Gross Margin 134
      • 7.18.3. Product portfolio 135
      • 7.18.4. Recent initiatives 136
  • Chapter 8. Plasmid  — Industry Analysis 137
    • 8.1. Plasmid  Market – Key Trends 137
      • 8.1.1. Market Drivers 138
      • 8.1.2. Market Restraints 138
      • 8.1.3. Market Opportunities 139
    • 8.2. Value Chain Analysis 140
    • 8.3. Technology Roadmap and Timeline 141
    • 8.4. Plasmid  Market – Attractiveness Analysis 142
      • 8.4.1. By General Type Plasmid 142
      • 8.4.2. By Specific Plasmid Types 142
      • 8.4.3. By Application 143
      • 8.4.4. By Region 145
  • Chapter 9. Marketing Strategy Analysis, Distributors 146
    • 9.1. Marketing Channel 146
    • 9.2. Direct Marketing 147
    • 9.3. Indirect Marketing 147
    • 9.4. Marketing Channel Development Trend 147
    • 9.5. Economic/Political Environmental Change 148
  • Chapter 10. Report Conclusion 149
  • Chapter 11. Research Approach & Methodology 150
    • 11.1. Report Description 150
    • 11.2. Research Scope 151
    • 11.3. Research Methodology 151
      • 11.3.1. Secondary Research 152
      • 11.3.2. Primary Research 153
      • 11.3.3. Models 154
        • 11.3.3.1. Company Share Analysis Model 154
        • 11.3.3.2. Revenue Based Modeling 155
        • 11.3.3.3. Research Limitations 155

Industry Major Market Players

Safe and Secure SSL Encrypted

Choose License Type  

Inquiry For Buying
Facts & Factors provides an array of marketing and business research solutions distinctly designed by our expertise for the clients.
Copyright © 2019 Facts & Factors. All Rights Reserved. Sitemap - Privacy Policy - Terms & Conditions